Description of the medicine: Testobromlecithum (Testobromlecithum)
White coated tablets with a yellowish tint, containing methyltestosterone 0.005 g, bromized 0.1 g and lecithin 0.05 g.
The main active ingredient is methyltestosterone, which has androgenic and low anabolic activity; bromized and lecithin have a calming effect on the central nervous system and improve metabolic processes.
Used in men with autonomic nervous disorders associated with insufficiency of the function of the sex glands, with menopause, neurasthenia, overwork, neurotic forms of angina pectoris, etc.
Women are prescribed for menopausal syndrome or after surgery for cancer of the ovaries, uterus, as well as for functional uterine bleeding.
Take sublingually or orally. In the first few days, men are prescribed 1 to 2 tablets 3 times a day, then 1 tablet 2 to 3 times a day. The course of treatment lasts 1 to 2 months; if necessary, repeat the treatment after a 3-4 month break.
Women with functional bleeding in the premenopausal period are prescribed 2 to 4 tablets per day for 2 to 4 weeks; with the phenomena of pathological menopause - 1 tablet 1 time per day until the cessation of pathological disorders.
The drug is contraindicated in liver damage, adenoma and prostate cancer.
Release form: tablets in packing of 25 pieces.
Storage: List B. In a dry, dark place.
Rp :. Tab. <Testobromlecithum> obd.